CIBC Private Wealth Group
ZSAN

CIBC Private Wealth Group’s Zosano Pharma Corporation ZSAN Stock Holding History

CIBC Private Wealth Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-457
Closed -$34K – 958
2018
Q4 		$34K Sell
457
-457
-50% -$57.9K ﹤0.01% 859
2018
Q3 		$131K Hold
914
– – ﹤0.01% 938
2018
Q2 		$131K Buy
+914
New +$138K ﹤0.01% 988
2018
Q1 		– Sell
-147
Closed -$54K – 2117
2017
Q4 		$54K Hold
147
– – ﹤0.01% 1169
2017
Q3 		$85K Buy
+147
New +$108K ﹤0.01% 911

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC Private Wealth Group's ZSAN Position: Q1 2019 in Review

CIBC Private Wealth Group sold out of Zosano Pharma Corporation (ZSAN) in Q1 2019, closing a stake of 457 shares — an estimated $34K sold.

CIBC Private Wealth Group first reported a position in ZSAN in Q3 2017 and held it in 5 quarters. The position peaked at $131K in Q3 2018. 19 funds tracked by Wall St. Rank hold ZSAN as of Q1 2019.

  • CIBC Private Wealth Group reported no remaining Zosano Pharma Corporation position as of Q1 2019 after selling out during the quarter.
  • CIBC Private Wealth Group sold 457 Zosano Pharma Corporation shares in Q1 2019, an estimated $34K.
  • CIBC Private Wealth Group first reported a position in Zosano Pharma Corporation in Q3 2017 and held it in 5 quarters.
  • CIBC Private Wealth Group's Zosano Pharma Corporation position peaked at $131K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2019.

Based on CIBC Private Wealth Group's 13F filing for Q1 2019, filed 10 May 2019.